Diabetes treatment depends on the type you have, but the core goal is always the same: keeping blood sugar within a healthy range to prevent complications. Type 1 diabetes requires insulin from the day of diagnosis. Type 2 diabetes typically starts with lifestyle changes and oral medication, then adds other therapies as needed. Both types benefit from blood sugar monitoring, nutritional planning, and physical activity.
Type 1 Diabetes: Insulin Is Essential
In type 1 diabetes, the immune system destroys the cells in the pancreas that produce insulin. Without insulin, your body cannot move sugar from the bloodstream into cells for energy. That makes insulin replacement the foundation of treatment, and it’s needed for life.
Most people with type 1 deliver insulin in one of two ways. Insulin pens are the most common injection method. Newer “smart” pens include built-in dose calculators, memory functions that log the amount and time of each injection, and Bluetooth that sends dose data to a phone app. Some pens allow half-unit dosing, which is especially useful for children who need smaller, more precise amounts.
Insulin pumps are small devices worn on the body that deliver a continuous stream of insulin through a tiny tube under the skin. Current pumps are compact and feature dose calculators and alarms. When a pump is paired with a continuous glucose monitor, the system can automatically suspend insulin delivery for up to two hours if blood sugar drops too low and the wearer doesn’t respond to an alert. The most advanced versions, sometimes called closed-loop or “artificial pancreas” systems, adjust insulin delivery throughout the day with minimal manual input.
There is also an inhaled insulin option called Afrezza, a dry powder you breathe in before meals. It starts working within about 15 minutes and lasts two to three hours, which makes it useful for covering the blood sugar spike after eating. It doesn’t replace the need for a long-acting insulin, though.
Type 2 Diabetes: First-Line Medication
Metformin has been the standard starting medication for type 2 diabetes for decades. It works primarily by reducing the amount of sugar your liver releases into the bloodstream and by helping your cells respond better to insulin. The typical starting dose is 500 mg once or twice a day, gradually increased over several weeks to reduce stomach side effects like nausea and diarrhea. Most people end up on a maintenance dose of 850 to 1,000 mg twice daily.
Metformin isn’t suitable for everyone. People with severe kidney problems, significant liver disease, or unstable heart failure generally cannot take it safely. For those who tolerate it well, it remains a highly effective, low-cost option that doesn’t cause weight gain and rarely causes dangerously low blood sugar on its own.
Newer Medications With Added Benefits
When metformin alone isn’t enough, or when a person has additional health concerns like obesity or heart disease, doctors now have several powerful medication classes to add.
GLP-1 and Dual-Action Drugs
A class of injectable and oral medications that mimic a gut hormone called GLP-1 has transformed type 2 treatment. These drugs stimulate insulin release when blood sugar is high, slow digestion, and reduce appetite. The weight loss effects are significant. Oral semaglutide at prescription doses can lower A1C (a three-month blood sugar average) by up to 1.4% while reducing body weight by about 10 pounds.
Tirzepatide, which activates two gut hormone receptors instead of one, goes further. In clinical trials, it produced an average weight loss of 15% over 72 weeks in people with obesity. That’s roughly 40 pounds for someone starting at 270. Several newer oral versions of these drugs are in late-stage development, with one called orforglipron producing weight loss of up to 14.7% over 36 weeks in trials.
SGLT2 Inhibitors
These medications work through an entirely different pathway. They block a protein in the kidneys that normally reabsorbs sugar back into the bloodstream, causing you to excrete 30% to 60% more glucose through urine. The result is lower blood sugar, modest weight loss, and lower blood pressure.
What makes SGLT2 inhibitors especially valuable is their effect on the heart and kidneys. In large clinical trials, several drugs in this class significantly reduced hospitalizations for heart failure and slowed kidney disease progression. These benefits appear even in people who don’t have diabetes, which is why some of these medications are now also prescribed specifically for heart failure.
Lifestyle Changes That Move the Needle
Medication works best alongside changes to eating and activity patterns, and for some people with type 2, lifestyle changes can be powerful enough to reduce or eliminate the need for medication entirely.
Weight loss is the single most impactful lifestyle change for type 2 diabetes. Losing just 5% of body weight (about 10 pounds for a 200-pound person) is enough to meaningfully improve how well your body uses insulin. The benefits scale up from there. An American Diabetes Association consensus report identifies 15% or more weight loss as the goal for optimal outcomes when it’s needed and can be achieved safely.
There is no single “diabetes diet.” What matters most is a consistent eating pattern that controls portions, limits refined carbohydrates and added sugars, and emphasizes vegetables, whole grains, lean protein, and healthy fats. Working with a registered dietitian for a personalized nutrition plan is one of the most effective interventions available, though it’s underused.
Regular physical activity improves insulin sensitivity for up to 48 hours after a session. Both aerobic exercise (walking, cycling, swimming) and resistance training (weights, bodyweight exercises) help. Current guidelines recommend at least 150 minutes of moderate-intensity activity per week, spread across at least three days with no more than two consecutive days off.
Blood Sugar Monitoring
Knowing your blood sugar levels throughout the day is what allows you to make informed decisions about food, activity, and medication. Traditional finger-stick meters give a snapshot at the moment you test. Continuous glucose monitors (CGMs), small sensors worn on the arm or abdomen, provide readings every few minutes and show trends over time.
The key metric with CGM is “time in range,” the percentage of the day your blood sugar stays between 70 and 180 mg/dL. The target for most people with diabetes is at least 70% of the day in range. In a study of people with type 2 diabetes, CGM users increased their time in range from about 56% to 61% over 24 weeks, while also spending less time with dangerously low blood sugar. That improvement translates to roughly 1.2 fewer hours per day spent with blood sugar too high or too low.
Handling Low Blood Sugar
Anyone taking insulin or certain other diabetes medications can experience hypoglycemia, when blood sugar drops below 70 mg/dL. Symptoms include shakiness, sweating, confusion, and irritability. The standard treatment is the 15-15 rule recommended by the CDC: eat or drink 15 grams of fast-acting carbohydrates (four glucose tablets, 4 ounces of juice, or a tablespoon of honey), wait 15 minutes, then recheck your blood sugar. Repeat if it’s still low. Once it normalizes, eat a small snack or meal to keep it stable.
Metabolic Surgery for Type 2 Diabetes
Bariatric surgery, increasingly called metabolic surgery when performed to treat diabetes, is the most effective intervention for achieving remission of type 2 diabetes in people with obesity. It’s typically considered for people with a BMI of 35 or higher who haven’t reached their blood sugar goals with medication, though there is growing evidence supporting surgery at lower BMIs as well. In one landmark trial, the average BMI of participants was 37, and over a third had a BMI below 35.
The remission rates are striking. In the STAMPEDE trial, 29% of people who had gastric bypass surgery achieved an A1C of 6% or lower at five years, compared to just 5% of those on intensive medical therapy alone. A ten-year follow-up of a different trial found that 50% of patients who had a more extensive surgical procedure maintained remission a full decade later, versus 5.5% in the medication-only group.
Remission, as defined by an international expert consensus, means an A1C below 6.5% sustained for at least three months without any diabetes medication. It’s important to understand that remission is not the same as a cure. Blood sugar can rise again over time, and long-term monitoring remains necessary.
How Treatment Evolves Over Time
Diabetes is a progressive condition, particularly type 2. The treatment that works at diagnosis may not be sufficient five or ten years later. The pancreas gradually produces less insulin over time, which often means adding medications or eventually starting insulin. This isn’t a failure on your part. It’s the natural course of the disease.
Many people with type 2 diabetes will use a combination of two or three medications from different classes, each targeting blood sugar through a different mechanism. A common combination might be metformin for baseline control, a GLP-1 drug for additional blood sugar lowering and weight management, and an SGLT2 inhibitor for cardiovascular or kidney protection. Your treatment plan will be adjusted based on A1C results, which are typically checked every three to six months, along with changes in weight, kidney function, and overall health.